Skip to content
10-Q

Quarterly Report

LIFECORE BIOMEDICAL, INC. LFCR

0001005286-26-000020

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 29, 2026 37.51M sh
Shares Diluted Q1 2026 · Mar 31, 2026 37.48M sh
Shares Diluted Q1 2026 · Feb 23, 2025 37.02M sh
Capex Q1 2026 · Mar 31, 2026 $1.12M
Capex Q1 2026 · Feb 23, 2025 $5.46M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $4.7M
Operating Cash Flow Q1 2026 · Feb 23, 2025 $1.2M
Short Term Debt Q1 2026 · Mar 31, 2026 $962K
Short Term Debt Q1 2026 · Dec 31, 2025 $954K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $20.8M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $17.47M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$28.44M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$14.2M
Stockholders Equity Q1 2026 · Feb 23, 2025 $2.23M
Stockholders Equity Q1 2026 · Nov 24, 2024 $15.45M
Current Liabilities Q1 2026 · Mar 31, 2026 $20.5M
Current Liabilities Q1 2026 · Dec 31, 2025 $23.57M
Total Liabilities Q1 2026 · Mar 31, 2026 $204.72M
Total Liabilities Q1 2026 · Dec 31, 2025 $198.12M
Current Assets Q1 2026 · Mar 31, 2026 $77.64M
Current Assets Q1 2026 · Dec 31, 2025 $82.29M
Total Assets Q1 2026 · Mar 31, 2026 $225.5M
Total Assets Q1 2026 · Dec 31, 2025 $232.18M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.43
Eps Diluted Q1 2026 · Feb 23, 2025 −$0.42
Eps Basic Q1 2026 · Mar 31, 2026 −$0.43
Eps Basic Q1 2026 · Feb 23, 2025 −$0.42
Sga Expense Q1 2026 · Mar 31, 2026 $7.92M
Sga Expense Q1 2026 · Feb 23, 2025 $9.98M
Rd Expense Q1 2026 · Mar 31, 2026 $1.22M
Rd Expense Q1 2026 · Feb 23, 2025 $2.05M
Net Income Q1 2026 · Mar 31, 2026 −$14.98M
Net Income Q1 2026 · Feb 23, 2025 −$14.77M
Operating Income Q1 2026 · Mar 31, 2026 −$4.67M
Operating Income Q1 2026 · Feb 23, 2025 −$9.03M
Gross Profit Q1 2026 · Mar 31, 2026 $4.46M
Gross Profit Q1 2026 · Feb 23, 2025 $9.85M